Al-Sawaf O, Robrecht S, Zhang C, Olivieri S, et al. Venetoclax-Obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the phase 3 CLL14 study. Blood 2024 Jul 10:blood.2024024631. doi: 10.1182/blood.2024024631.
PMID: 39082668